RNU6-408P

Across TCGA pan-cancer cohorts, RNU6-408P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-408P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-408P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-408P expression acts as an unfavorable survival marker.

STAD, UCEC, and SARC are the cancer types where RNU6-408P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.089	0.539	.003	36	view →
UCEC	DFS	Tertile	All	0.100	0.646	.024	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
BLCA	OS	Tertile	All	0.248	0.720	.026	27	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-408P–STAD (OS)

Open the STAD breakdown →